![](https://cdn.sanity.io/images/0vv8moc6/psychtimes/4fb7f755c12e6828e87102e15a4bfd778af593a5-880x880.jpg?fit=crop&auto=format)
New Data on the Subcutaneous Long-Acting Injectable Antipsychotic Formulation of Risperidone
"Schizophrenia doesn't stop at any door..." Christoph U. Correll, MD, shared exciting updates from the recent RISE study on TV-46000, a subcutaneous long-acting injectable antipsychotic formulation of risperidone, which is approved by the …